137 related articles for article (PubMed ID: 30034881)
41. Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection.
Nantasenamat C; Monnor T; Worachartcheewan A; Mandi P; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2014 Apr; 76():352-9. PubMed ID: 24589490
[TBL] [Abstract][Full Text] [Related]
42. Modeling GC-ECD retention times of pentafluorobenzyl derivatives of phenol by using artificial neural networks.
Asadpour-Zeynali K; Jalili-Jahani N
J Sep Sci; 2008 Dec; 31(21):3788-95. PubMed ID: 18956382
[TBL] [Abstract][Full Text] [Related]
43. Predicting rejection of emerging contaminants through RO membrane filtration based on ANN-QSAR modeling approach: trends in molecular descriptors and structures towards rejections.
Mousavi SL; Sajjadi SM
RSC Adv; 2023 Aug; 13(34):23754-23771. PubMed ID: 37560620
[TBL] [Abstract][Full Text] [Related]
44. N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies.
Maurya SS; Bahuguna A; Khan SI; Kumar D; Kholiya R; Rawat DS
Eur J Med Chem; 2019 Jan; 162():277-289. PubMed ID: 30448417
[TBL] [Abstract][Full Text] [Related]
45. QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against
Adeniji SE; Uba S; Uzairu A
J Pathog; 2018; 2018():1018694. PubMed ID: 29862081
[TBL] [Abstract][Full Text] [Related]
46. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
[TBL] [Abstract][Full Text] [Related]
47. ANN-QSAR model for virtual screening of androstenedione C-skeleton containing phytomolecules and analogues for cytotoxic activity against human breast cancer cell line MCF-7.
Prakash O; Khan F; Sangwan RS; Misra L
Comb Chem High Throughput Screen; 2013 Jan; 16(1):57-72. PubMed ID: 23030276
[TBL] [Abstract][Full Text] [Related]
48. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
[TBL] [Abstract][Full Text] [Related]
49. Anti-gastric cancer activity of 1,2,3-triazolo[4,5-d]pyrimidine hybrids (1,2,3-TPH): QSAR and molecular docking approaches.
Kolawole OA; Olatomide A F; Banjo S
Heliyon; 2020 Mar; 6(3):e03561. PubMed ID: 32215327
[TBL] [Abstract][Full Text] [Related]
50. Quantitative Structure-Activity Relationship (QSAR) Modelling of Indomethacin Derivatives Using Regression Analysis.
Shukla N; Sharma B
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37818563
[TBL] [Abstract][Full Text] [Related]
51. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
[TBL] [Abstract][Full Text] [Related]
52. QSAR Models for Predicting Aquatic Toxicity of Esters Using Genetic Algorithm-Multiple Linear Regression Methods.
Rajabi M; Shafiei F
Comb Chem High Throughput Screen; 2019 Aug; 22(5):317-325. PubMed ID: 31215375
[TBL] [Abstract][Full Text] [Related]
53. QSAR modeling for the antimalarial activity of 1,4-naphthoquinonyl derivatives as potential antimalarial agents.
Luan F; Xu X; Cordeiro MN; Liu H; Zhang X
Curr Comput Aided Drug Des; 2013 Mar; 9(1):95-107. PubMed ID: 23157413
[TBL] [Abstract][Full Text] [Related]
54. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
[TBL] [Abstract][Full Text] [Related]
55. In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors.
Parihar N; Nandi S
Springerplus; 2015; 4(1):819. PubMed ID: 29021931
[TBL] [Abstract][Full Text] [Related]
56. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
57. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
Dolezal R; Van Damme S; Bultinck P; Waisser K
Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
[TBL] [Abstract][Full Text] [Related]
58. A search for sources of drug resistance by the 4D-QSAR analysis of a set of antimalarial dihydrofolate reductase inhibitors.
Santos-Filho OA; Hopfinger AJ
J Comput Aided Mol Des; 2001 Jan; 15(1):1-12. PubMed ID: 11217916
[TBL] [Abstract][Full Text] [Related]
59. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
60. 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents.
Hadni H; Elhallaoui M
Heliyon; 2020 Apr; 6(4):e03580. PubMed ID: 32322700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
